Updated Jul 16, 2026
KAO JOHN E has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $65.55M.

John E. Kao is the Chief Executive Officer and Director of Alignment Healthcare, Inc., a company focused on transforming healthcare experiences for seniors through innovative Medicare Advantage plans. He has played a significant role in leading the company's consumer-centric healthcare initiatives.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 18.4K | $20.65 | $379K |
| 2026-07-14 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 279.6K | $19.81 | $5.54M |
| 2026-06-12 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 223.1K | $20.60 | $4.59M |
| 2026-06-12 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 74.9K | $19.65 | $1.47M |
| 2026-05-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 17.1K | $17.54 | $300K |
| 2026-05-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 280.9K | $16.85 | $4.73M |
| 2026-04-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 82.3K | $20.80 | $1.71M |
| 2026-04-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 13.8K | $21.38 | $295K |
| 2026-04-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 201.9K | $20.58 | $4.16M |
| 2026-04-08 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 117.8K | $21.40 | $2.52M |
| 2026-04-08 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 132.2K | $20.67 | $2.73M |
| 2026-03-23 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 118.0K | $17.48 | $2.06M |
| 2026-03-19 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 73.0K | $17.84 | $1.30M |
| 2026-03-17 | ALHC | Alignment Healthcare, Inc. | A — Grant or award | 338.4K | $0.00 | |
| 2026-03-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 3.0K | $16.99 | $50K |
| 2026-03-13 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 45.9K | $17.48 | $803K |
| 2026-03-10 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 180.0K | $18.19 | $3.27M |
| 2026-02-11 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale [10b5-1] | 180.0K | $20.49 | $3.69M |
| 2025-10-10 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 180.0K | $17.29 | $3.11M |
| 2025-09-10 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 180.0K | $16.42 | $2.95M |
John E. Kao is the Chief Executive Officer and Director of Alignment Healthcare, Inc., a company focused on transforming healthcare experiences for seniors through innovative Medicare Advantage plans. He has played a significant role in leading the company's consumer-centric healthcare initiatives.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 30 open-market sales ($65.55M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KAO JOHN E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.